Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. reports recurring developments in outpatient diagnostic imaging, digital health, and radiology technology. The company operates owned and managed imaging centers that provide MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, nuclear medicine, and related procedures for physicians and patients across U.S. markets.
RadNet news commonly covers financial results, imaging-center procedure volumes, guidance updates, joint ventures, acquisitions, and customer or technology collaborations. Its Digital Health segment includes DeepHealth, which provides radiology information technology, AI-powered health informatics, clinical AI applications, patient engagement tools, operational AI, teleradiology services, and related products for the diagnostic imaging industry.
RadNet (NASDAQ: RDNT) will host a free public Men’s Health webinar on Saturday, June 13, 2026, during National Men’s Health Month.
Leading radiologists will discuss coronary artery disease, prostate cancer and lung cancer, focusing on risk factors, screening criteria and the role of diagnostic imaging in early detection.
RadNet (NASDAQ: RDNT) reported record first quarter 2026 results, with revenue up 22.1% to $575.6 million and Adjusted EBITDA(1) up 36.3% to $63.3 million. Digital Health revenue grew 51.5% to $29.1 million and ARR(4) rose to $96.9 million.
Advanced imaging volumes increased 19.7% systemwide. Adjusted diluted loss per share(3) improved to $(0.28). RadNet raised 2026 Imaging Center guidance for revenue to $2.355–$2.405 billion, Adjusted EBITDA(1) to $340–$353 million, and Free Cash Flow(2) to $112–$122 million, and reaffirmed all Digital Health guidance ranges.
RadNet (NASDAQ: RDNT) formed a joint venture with Saint Alphonsus Health System by acquiring a majority equity stake in Intermountain Medical Imaging, owner of five outpatient multimodality imaging centers in Boise, Idaho.
RadNet will manage operations, Gem State Radiology will continue professional services with ~30 radiologists, and the centers will deploy DeepHealth clinical, reporting, AI and operations suites. The joint venture is projected to generate approximately $30 million in annual revenue.
RadNet (NASDAQ: RDNT) will host a conference call to discuss its first quarter 2026 financial results on Monday, May 11, 2026 at 7:30 a.m. PT (10:30 a.m. ET). Investors may join by phone or listen to simultaneous and archived webcasts.
Dial-in, international numbers, webcast link, and replay passcode are provided for live participation and later access.
GE HealthCare (Nasdaq: GEHC) expanded its collaboration with DeepHealth (RadNet subsidiary) to commercially extend DeepHealth’s AI-powered Breast Suite internationally and integrate new applications with GE’s Pristina Via mammography systems. The deal adds ProFound Pro, Safeguard Review, and cloud-first workflow tools to scale AI-enabled breast cancer screening and second‑reader workflows.
RadNet (NASDAQ: RDNT) announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026 at 4:30 p.m. ET (1:30 p.m. PT). Live and archived webcasts are available at the provided webcast link.
RadNet (NASDAQ: RDNT) announced that CFO Mark Stolper will present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12, 2026 at 8:00 a.m. ET / 5:00 a.m. PT.
A live webcast and archived replay will be available, and the in-person presentation is scheduled at Loews Miami Beach Hotel.
DeepHealth (NASDAQ: RDNT) unveiled at ECR 2026 a cloud-first, integrated portfolio of native clinical AI solutions across MR, CT, X-ray, mammography and ultrasound, plus the acquisition of Gleamer to expand musculoskeletal and X-ray capabilities.
Key validated results include a 21% breast cancer detection increase across 579,000 women, 92% sensitivity for hippocampal atrophy, deployment across >200 RadNet sites with >94% AI measurement acceptance, and AI Studio aggregating >140 algorithms from 75 partners.
RadNet (NASDAQ: RDNT) will present at the Raymond James 47th Annual Institutional Investors Conference in Orlando on Tuesday, March 3, 2026 at 2:15 p.m. ET. Mark Stolper, EVP and Chief Financial Officer, will deliver the presentation.
A live webcast is available and replay-capable via the company's webcast link, and the conference is at the JW Marriott Grande Lakes, Orlando.
RadNet (NASDAQ: RDNT) reported a quarterly record $547.7M revenue and $87.7M Adjusted EBITDA for Q4 2025, increases of 14.8% and 16.9% year-over-year respectively. Full-year 2025 revenue was $2,040.2M with Adjusted EBITDA of $300.2M.
The company reported strong advanced imaging volume growth, Digital Health momentum (Q4 revenue $27.9M), the Gleamer acquisition, and 2026 guidance calling for double-digit revenue and EBITDA growth across segments.